Apheresis red blood cells associated with repeated hemolysis during blood priming of the Cellex Photopheresis System.

abstract：:Treatment by low density lipoprotein (LDL) apheresis using dextran sulfate columns (DSC) leads to hemostasis alterations with prolonged activated partial thromboplastin time (APTT) of more than 120 seconds. In order to explain this hypocoagulability, we studied hemostasis parameters both in patients and in the extraco...

journal_title：Journal of clinical apheresis

authors： Lorenzini JL,Dutrillaux F,Mousson C,Lassale B,Maynadié M,Rifle G

更新日期：1993-01-01 00:00:00

abstract：:The combined use of immunoadsorption (IA) and membrane filtration (MF) may markedly enhance removal of IgM and complement component C1q, supporting its use as an element of recipient desensitization in antibody-incompatible transplantation. However, coagulation factor removal may contribute to altered hemostasis, posi...

journal_title：Journal of clinical apheresis

authors： Biesenbach P,Eskandary F,Ay C,Wiegele M,Derfler K,Schaden E,Haslacher H,Oberbauer R,Böhmig GA

更新日期：2016-02-01 00:00:00

abstract：:"Leukocyte-depleted" platelet concentrates (LD-SDPC) were prepared by cotton-wool and by polyester filtration of "leukocyte-poor" PC collected by the elutriation technique. The storage characteristics of LD-SDPC were comparable to those of the filtered pools of multiple donor platelet concentrates (LD-MDPC). However, ...

journal_title：Journal of clinical apheresis

authors： Elias MK,de Wolf JT,Blom N,Rijskamp L,Halie RM,Smit Sibinga CT

更新日期：1991-01-01 00:00:00

abstract：:We have recognized marked effectiveness for intermittent claudication with low-density lipoprotein (LDL) apheresis in two cases of arteriosclerosis obliterans (ASO). The Case 1 was a 73-year-old man with intermittent claudication of both lower extremities (Fontaine class II), digital subtraction angiography (DSA) reve...

journal_title：Journal of clinical apheresis

authors： Suzuki T,Sato Y,Niizuma S,Kushiro T,Tani S,Ishikawa K,Kajiwara N,Kanmatsuse K,Ikeda H,Takahashi M,Kojima S

更新日期：2007-01-01 00:00:00

abstract：:An improved method for intermittent-flow erythrocytapheresis in patients with sickle cell disease is reported. The method, a modification of the standard red cell exchange procedure for the Haemonetics 30S unit, dilutes with physiologic saline the patient's blood as it flows from the draw line and before it reaches th...

journal_title：Journal of clinical apheresis

authors： Castro O,Finke-Castro H,Coats D

更新日期：1986-01-01 00:00:00

abstract：:There are currently no licensed vaccines or therapeutics for COVID-19. Anti-SARS CoV-2 antibody-containing plasmas, obtained from the recovered individuals who had confirmed COVID-19, have been started to be collected using apheresis devices and stored in blood banks in some countries in order to administer to the pat...

journal_title：Journal of clinical apheresis

authors： Yiğenoğlu TN,Hacıbekiroğlu T,Berber İ,Dal MS,Baştürk A,Namdaroğlu S,Korkmaz S,Ulas T,Dal T,Erkurt MA,Turgut B,Altuntaş F

更新日期：2020-08-01 00:00:00

abstract：:Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease treated successfully with plasma exchange. Jehovah's Witnesses whose religious beliefs preclude them from accepting plasma exchange may require alternative forms of therapy. We report a case of one such patient who presented with TTP, whom we succ...

journal_title：Journal of clinical apheresis

authors： Dabak V,Kuriakose P,Raman S

更新日期：2007-01-01 00:00:00

abstract：:The purpose of this study is to determine whether immunoadsorption treatment using a dextran sulfate (DS) column can remove high-avidity anti-double-stranded DNA (anti-dsDNA) antibody from the blood of patients with systemic lupus erythematosus (SLE). Before and after each immunoadsorption therapy routine, titers of t...

journal_title：Journal of clinical apheresis

authors： Matsuki Y,Suzuki K,Kawakami M,Ishizuka T,Kawaguchi Y,Hidaka T,Nakamura H

更新日期：1996-01-01 00:00:00

abstract：INTRODUCTION:ABO- or HLA-incompatible kidney transplantation is possible thanks to pretransplant antibody-depletion achieved by extracorporeal-treatment modalities. These methods induce depletion of some plasma proteins and may also impact on proteins involved in hemostasis. METHODS:To determine the impact of one sess...

journal_title：Journal of clinical apheresis

authors： Marlu R,Bennani HN,Seyve L,Malvezzi P,Janbon B,Noble J,Christophe M,Motte L,Imerzoukene F,Chevallier E,Rostaing L,Jouve T

更新日期：2020-08-17 00:00:00

abstract：INTRODUCTION:Algorithms have been developed to predict the platelet yield after apheresis from the donor's data, as well as the effect on the blood cell count, to extract an acceptable platelet number without affecting the donor. However, the evaluation of these algorithms has not been widely reported. This study aimed...

journal_title：Journal of clinical apheresis

authors： Cienfuegos-Pecina E,Ayala-De la Cruz S,Leal-Nava ER,Pérez-Olvera JA,Llaca-Díaz JM,Avilés-Rodríguez LE,Pérez-Chávez F,Díaz-Chuc EA

更新日期：2020-10-05 00:00:00

abstract：:For many years dextran sulfate adsorption (DSA) treatment of separated plasma has been an established technology for low-density lipoprotein (LDL)-elimination. Recently a system for the treatment of whole blood based on DSA was introduced into clinical practice. To further characterize DSA treatment of whole blood, th...

journal_title：Journal of clinical apheresis

authors： Julius U,Parhofer KG,Heibges A,Kurz S,Klingel R,Geiss HC

更新日期：2007-01-01 00:00:00

abstract：BACKGROUND:Securing adequate vascular access is essential for a successful apheresis procedure. In most, peripheral access is preferred but it is not always technically possible. Ultrasound-Guided Peripheral Vascular Access (USG-PIVA) is a well-documented technique in the setting of Emergency departments. However, limi...

journal_title：Journal of clinical apheresis

authors： Putensen D,Pilcher L,Collier D,McInerney K

更新日期：2016-12-01 00:00:00

abstract：:Either bone marrow or peripheral blood may be harvested to provide hematopoietic stem cells (HSC) for autologous transplantation. Both, however, comprise heterogeneous cell populations. The HSC necessary for successful engraftment constitute a very small fraction of the cells harvested. After collection, the harvested...

journal_title：Journal of clinical apheresis

authors： Rowley SD

更新日期：1992-01-01 00:00:00

abstract：:Graphite furnace atomic absorption spectroscopy was used to demonstrate a fivefold increase in the median plasma aluminium levels of four patients undergoing therapeutic plasmapheresis. This plasma aluminium loading resulted from contamination of albumin incorporated in the replacement fluids and took place during its...

journal_title：Journal of clinical apheresis

authors： Monteagudo F,Wood L,Jacobs P,Folb P,Cassidy M

更新日期：1987-01-01 00:00:00

abstract：:We present clinical data on two boys with chronic relapsing polyneuropathy. Their recurrent episodes of weakness had produced marked disability which was unresponsive to continuous prednisone therapy. Plasmapheresis produced dramatic improvement in muscle strength and functional ability. The remissions induced have be...

journal_title：Journal of clinical apheresis

authors： Connor RK,Ziter FA,Anstall HB

更新日期：1982-01-01 00:00:00

abstract：:Plerixafor in combination with granulocyte-colony stimulating factor (G-CSF) is approved for autologous stem cell mobilization in poor mobilizing patients with multiple myeloma or malignant lymphoma. The purpose of this study was to evaluate efficacy and safety of plerixafor in an immediate rescue approach, administra...

journal_title：Journal of clinical apheresis

authors： Worel N,Fritsch G,Agis H,Böhm A,Engelich G,Leitner GC,Geissler K,Gleixner K,Kalhs P,Buxhofer-Ausch V,Keil F,Kopetzky G,Mayr V,Rabitsch W,Reisner R,Rosskopf K,Ruckser R,Zoghlami C,Zojer N,Greinix HT

更新日期：2017-08-01 00:00:00

abstract：:The practice of transfusing ABO-incompatible platelets, driven primarily by concerns about inventory management, has been considered generally safe because the accompanying plasma is usually diluted in the recipient's total blood volume. However, if the platelet product contains a large volume of plasma or a high conc...

journal_title：Journal of clinical apheresis

authors： Sapatnekar S,Sharma G,Downes KA,Wiersma S,McGrath C,Yomtovían R

更新日期：2005-12-01 00:00:00

abstract：BACKGROUND:Patients undergoing therapeutic plasma exchange (TPE) may present with risks for hemorrhage or thrombosis. Use of replacement fluids devoid of coagulation factors will decrease factor levels and platelet levels. There are no established guidelines for hemostasis management in these situations. MATERIALS AND...

journal_title：Journal of clinical apheresis

authors： Zantek ND,Boral LI,Li Y,Yamada C,Svensson AM,Crane JE,Smith RE,Pagano MB,Rollins-Raval MA,Schmidt AE,Wong ECC,Wu Y

更新日期：2018-10-01 00:00:00

abstract：:Focal segmental glomerulosclerosis (FSGS) recurs in 30% of renal allograft transplants with graft loss in half of the cases. A humoral factor may be implicated. We report on the use of therapeutic plasma exchange (TPE) in 11 patients with recurrent FSGS post transplantation. Medical records from 1989-2000 were reviewe...

journal_title：Journal of clinical apheresis

authors： Shariatmadar S,Noto TA

更新日期：2002-01-01 00:00:00

abstract：:Although rituximab (RTX) is a promising therapeutic agent for treating steroid-resistant nephrotic syndrome (SRNS) resistant to various immunosuppressive agents, some patients have shown resistance to RTX. We report the case of a patient with RTX-resistant nephrotic syndrome and SRNS who was successfully treated with ...

journal_title：Journal of clinical apheresis

authors： Takakura M,Shimizu M,Mizuta M,Inoue N,Tasaki Y,Ohta K,Furuichi K,Wada T,Yachie A

更新日期：2018-06-01 00:00:00

abstract：PURPOSE:Wilson's disease is a rare autosomal recessive genetic disorder that results in accumulation of copper in the liver, brain, cornea and kidney. Therapeutic plasma exchange (TPE) has been used to remove copper and provide a bridge to liver transplantation. We report here the collective experiences through the ASF...

journal_title：Journal of clinical apheresis

authors： Pham HP,Schwartz J,Cooling L,Hofmann JC,Kim HC,Morgan S,Pagano MB,Schneiderman J,Winters JL,Yamada C,Wong EC,Wu Y

更新日期：2016-02-01 00:00:00

abstract：BACKGROUND:Currently, low titer A plasma is used on a routine basis in bleeding trauma patients of unknown AB type. Three AB non-bleeding apheresis patients are presented here who safely received a combination of AB and low titer A plasma during therapeutic plasma exchange (TPE). One control AB patient received AB plas...

journal_title：Journal of clinical apheresis

authors： Kaplan A,Sevcik J,Kiss JE

更新日期：2019-02-01 00:00:00

abstract：:Apheresis procedures in small children are technically challenging and require special planning with attention to extracorporeal volume. Discontinuous procedures such as extracorporeal photopheresis (ECP) require additional consideration. Alternative methods to perform ECP have been utilized in small children that req...

journal_title：Journal of clinical apheresis

authors： Schneiderman J,Jacobsohn DA,Collins J,Thormann K,Kletzel M

更新日期：2010-01-01 00:00:00

abstract：:We have reviewed our initial experience with a program of concurrent collection of plasma (CCP) during plateletpheresis, which was instituted to increase the number of units of fresh frozen plasma produced by our hospital-based donor service. Sixty percent of eligible donors (1,006 of 1,682) participated in CCP, and 2...

journal_title：Journal of clinical apheresis

authors： Burger SR,Thomas BT,Grishaber JE

更新日期：1994-01-01 00:00:00

abstract：BACKGROUND:The ability to cryopreserve a portion of the cells treated during extracorporeal photopheresis (ECP) would improve therapy logistics, particularly for pediatric patients, by allowing multiple therapeutic doses to be collected from a single apheresis session. However, the effect of cryopreservation on ECP-tre...

journal_title：Journal of clinical apheresis

authors： Radwanski K,Heber C,Min K

更新日期：2015-06-01 00:00:00

abstract：:Sickle cell disease (SCD) patients are prone to develop complications that include stroke, acute chest syndrome, and other crises. Some of these complications require chronic transfusion therapy or red cell exchange (RCE), either for therapeutic or prophylactic reasons. Due to a discrepancy of red cell antigens betwee...

journal_title：Journal of clinical apheresis

authors： Sarode R,Altuntas F

更新日期：2006-12-01 00:00:00

abstract：BACKGROUND:Autologous stem cell transplantation (auto-SCT) is a treatment approach in non-Hodgkin lymphoma (NHL) patients. The options for mobilization of CD34+ cells to support high-dose therapy are granulocyte-colony stimulating factors (G-CSFs) alone or after chemotherapy. Limited data exist on the efficacy of lipeg...

journal_title：Journal of clinical apheresis

authors： Partanen A,Turunen A,Valtola J,Vasala K,Ågren L,Penttilä K,Pyörälä M,Kuittinen T,Mäntymaa P,Pelkonen J,Jantunen E,Varmavuo V

更新日期：2020-08-01 00:00:00

abstract：:Blood products are frequently required immediately prior to, during, or just after an apheresis procedure. Transfusion-related acute lung injury (TRALI) is now the leading cause of transfusion-related mortality, surpassing ABO-incompatible hemolytic reactions. The reported incidence of TRALI varies but is estimated at...

journal_title：Journal of clinical apheresis

authors： Cruz J,Skipworth E,Blue D,Waxman D,McCarthy L,Smith D

更新日期：2008-01-01 00:00:00

abstract：:Modest success has been achieved with the use of high-dose cytotoxic therapy and bone marrow transplantation in solid tumors. Patient outcome can potentially be improved with further intensification of the therapy. The rapid hematologic recovery achieved with mobilized peripheral blood progenitor cells (PBPC) may redu...

journal_title：Journal of clinical apheresis

authors： Ghalie R,Richman CM,Bender JG,McLeod BC,Lee W,Czyzewski A,Manson S,Cobleigh MA,Reed S,Pierre R

更新日期：1994-01-01 00:00:00

abstract：:Over the past 37 year the role of plasma exchange in the treatment of patients with renal disease has undergone several changes. The majority of the changes for the use of plasma exchange relied on randomized control trials and delineations of mechanisms that potentially would benefit from the use of plasma exchange. ...

journal_title：Journal of clinical apheresis

authors： Clark WF

更新日期：2012-01-01 00:00:00